Announcement
Mathew Thomas, R. Pavelka, Hiroyasu Iishi(Itami City Hospital), Herbert Lochs(Humboldt-Universität zu Berlin), Paolo Carlini(National Cancer Institute), Rivka Katsnelson, Gian Bertelli, A. Yerushalmi, Köichi Fukumoto, Michael Frass(Medical University of Vienna), Andrea Ardizzoni(Azienda Ospedaliero-Universitaria Careggi), William A. Robinson(University of Colorado Anschutz Medical Campus), A.M. Abdel-Galil, PierFranco Conte(University of Padua), P. Pronzato(Accademia Nazionale dei Lincei), Enzo Maria Ruggeri, Claudio Caporali, R. Pötzi(Medical University of Vienna), Hisako Yamamura(Osaka International Cancer Institute), Francesco Cognetti(Apple (Israel)), Merrill Singer(University of Connecticut), J.H. Holzner, L. Michael Glode, Takeo Yoshikawa(RIKEN Center for Brain Science), Rita Lionetto, Nancy Morton, B. Dragosics, Paola Papaldo(Cancer Institute (WIA)), Peter Ferenci(University of Vienna), Massimo Lopez(Tumori Foundation), Shigeru Okuda, Ettore Conti(Tumori Foundation), Krsto Kolarić, Masaharu Tatsuta, F.X. Pesendorfer, K. Vinzenz, Hiroshi Kasugai, Y. Fishelovitz, K. Nishida, T.I. Mughal, Elliot Levy(National Institutes of Health), Anton Roth, Joseph Allen Stein, Riccardo Rosso(Ente Ospedaliero Ospedali Galliera), Masakazu Kondo, A. Shani, Luigi Di Lauro, Paola Pinnarò, Erica Rakowsky, J. Arielly
Cited by 1
Related Papers
Nivolumab in Previously Untreated Melanoma without <i>BRAF</i> Mutation
|New England Journal of Medicine|2014|5.3k
Gemcitabine and Cisplatin Versus Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Advanced or Metastatic Bladder Cancer: Results of a Large, Randomized, Multinational, Multicenter, Phase III Study
|Journal of Clinical Oncology|2000|2.3k
Randomized phase II trial of the efficacy and safety of trastuzumab combined with docetaxel in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer administered as first-line treatment: the M77001 study group.
|IRIS UNIMORE (University of Modena and Reggio Emilia)|2005|1.6k
Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease
|Nature Genetics|2009|1.3k
Mucosal flora in inflammatory bowel disease
|Gastroenterology|2002|1.3k